442 related articles for article (PubMed ID: 28931501)
1. Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol.
Katapodi MC; Viassolo V; Caiata-Zufferey M; Nikolaidis C; Bührer-Landolt R; Buerki N; Graffeo R; Horváth HC; Kurzeder C; Rabaglio M; Scharfe M; Urech C; Erlanger TE; Probst-Hensch N; Heinimann K; Heinzelmann-Schwarz V; Pagani O; Chappuis PO
JMIR Res Protoc; 2017 Sep; 6(9):e184. PubMed ID: 28931501
[TBL] [Abstract][Full Text] [Related]
2. Using a Tailored Digital Health Intervention for Family Communication and Cascade Genetic Testing in Swiss and Korean Families With Hereditary Breast and Ovarian Cancer: Protocol for the DIALOGUE Study.
Kim S; Aceti M; Baroutsou V; Bürki N; Caiata-Zufferey M; Cattaneo M; Chappuis PO; Ciorba FM; Graffeo-Galbiati R; Heinzelmann-Schwarz V; Jeong J; Jung MM; Kim SW; Kim J; Lim MC; Ming C; Monnerat C; Park HS; Park SH; Pedrazzani CA; Rabaglio M; Ryu JM; Saccilotto R; Wieser S; Zürrer-Härdi U; Katapodi MC
JMIR Res Protoc; 2021 Jun; 10(6):e26264. PubMed ID: 34114954
[TBL] [Abstract][Full Text] [Related]
3. Challenges and Opportunities for Cancer Predisposition Cascade Screening for Hereditary Breast and Ovarian Cancer and Lynch Syndrome in Switzerland: Findings from an International Workshop.
Nikolaidis C; Ming C; Pedrazzani C; van der Horst T; Kaiser-Grolimund A; Ademi Z; Bührer-Landolt R; Bürki N; Caiata-Zufferey M; Champion V; Chappuis PO; Kohler C; Erlanger TE; Graffeo R; Hampel H; Heinimann K; Heinzelmann-Schwarz V; Kurzeder C; Monnerat C; Northouse LL; Pagani O; Probst-Hensch N; Rabaglio M; Schoenau E; Sijbrands EJG; Taborelli M; Urech C; Viassolo V; Wieser S; Katapodi MC;
Public Health Genomics; 2018; 21(3-4):121-132. PubMed ID: 30695780
[TBL] [Abstract][Full Text] [Related]
4. Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort.
Sarki M; Ming C; Aissaoui S; Bürki N; Caiata-Zufferey M; Erlanger TE; Graffeo-Galbiati R; Heinimann K; Heinzelmann-Schwarz V; Monnerat C; Probst-Hensch N; Rabaglio M; Zürrer-Härdi U; Chappuis PO; Katapodi MC; On Behalf Of The Cascade Consortium
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406409
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
6. Interventions Facilitating Family Communication of Genetic Testing Results and Cascade Screening in Hereditary Breast/Ovarian Cancer or Lynch Syndrome: A Systematic Review and Meta-Analysis.
Baroutsou V; Underhill-Blazey ML; Appenzeller-Herzog C; Katapodi MC
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33672149
[TBL] [Abstract][Full Text] [Related]
7. The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.
Menko FH; Ter Stege JA; van der Kolk LE; Jeanson KN; Schats W; Moha DA; Bleiker EMA
Fam Cancer; 2019 Jan; 18(1):127-135. PubMed ID: 29846880
[TBL] [Abstract][Full Text] [Related]
8. Relatives from Hereditary Breast and Ovarian Cancer and Lynch Syndrome Families Forgoing Genetic Testing: Findings from the Swiss CASCADE Cohort.
Sarki M; Ming C; Aceti M; Fink G; Aissaoui S; Bürki N; Graffeo R; Heinimann K; Caiata Zufferey M; Monnerat C; Rabaglio M; Zürrer-Härdi U; Chappuis PO; Katapodi MC; The Cascade Consortium
J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294879
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer.
Vietri MT; D'Elia G; Caliendo G; Casamassimi A; Federico A; Passariello L; Cioffi M; Molinari AM
Med Oncol; 2021 Jan; 38(2):13. PubMed ID: 33484353
[TBL] [Abstract][Full Text] [Related]
10. Expert and Advocacy Group Consensus Findings on the Horizon of Public Health Genetic Testing.
Modell SM; Greendale K; Citrin T; Kardia SL
Healthcare (Basel); 2016 Jan; 4(1):. PubMed ID: 27417602
[TBL] [Abstract][Full Text] [Related]
11. Development of a Web-based Family Intervention for BRCA Carriers and Their Biological Relatives: Acceptability, Feasibility, and Usability Study.
Katapodi MC; Jung M; Schafenacker AM; Milliron KJ; Mendelsohn-Victor KE; Merajver SD; Northouse LL
JMIR Cancer; 2018 Apr; 4(1):e7. PubMed ID: 29653920
[TBL] [Abstract][Full Text] [Related]
12. Psychosocial barriers and facilitators for cascade genetic testing in hereditary breast and ovarian cancer: a scoping review.
Afaya A; Kim SW; Park HS; Lim MC; Jung MS; Nam EJ; Park JS; Jeong J; Ryu JM; Kim J; Kim J; Kim M; Jin J; Han J; Kim SY; Park SY; Katapodi MC; Kim S;
Fam Cancer; 2024 Jun; 23(2):121-132. PubMed ID: 38662264
[TBL] [Abstract][Full Text] [Related]
13. Low rates of cascade genetic testing among families with hereditary gynecologic cancer: An opportunity to improve cancer prevention.
Griffin NE; Buchanan TR; Smith SH; Leon AA; Meyer MF; Liu J; Tabak RG; Fuh KC; Thaker PH; Powell MA; Mutch DG; Massad LS; Colditz GA; Hagemann AR
Gynecol Oncol; 2020 Jan; 156(1):140-146. PubMed ID: 31780235
[TBL] [Abstract][Full Text] [Related]
14. Privacy and utility of genetic testing in families with hereditary cancer syndromes living in three countries: the international cascade genetic screening experience.
Barnoy S; Dagan E; Kim S; Caiata-Zufferey M; Katapodi MC; ;
Front Genet; 2023; 14():1109431. PubMed ID: 37229185
[No Abstract] [Full Text] [Related]
15. BRCAShare-Assessment of an animated digital message for intrafamilial communication of pathogenic variant positive test results: A feasibility study.
Aeilts AM; Carpenter KM; Hovick SR; Byrne L; Shoben AB; Senter L
J Genet Couns; 2023 Apr; 32(2):475-485. PubMed ID: 36426678
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms to increase cascade testing in hereditary breast and ovarian cancer: Impact of introducing standardized communication aids into genetic counseling.
Garcia C; Sullivan MW; Lothamer H; Harrison KM; Chatfield L; Thomas MH; Modesitt SC
J Obstet Gynaecol Res; 2020 Sep; 46(9):1835-1841. PubMed ID: 32656916
[TBL] [Abstract][Full Text] [Related]
17. Germline mutation prevalence in individuals with pancreatic cancer and a history of previous malignancy.
Dudley B; Karloski E; Monzon FA; Singhi AD; Lincoln SE; Bahary N; Brand RE
Cancer; 2018 Apr; 124(8):1691-1700. PubMed ID: 29360161
[TBL] [Abstract][Full Text] [Related]
18. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.
Schofield L; Goldblatt J; Iacopetta B
Rural Remote Health; 2011; 11(4):1836. PubMed ID: 22188021
[TBL] [Abstract][Full Text] [Related]
19. Predicting Openness of Communication in Families With Hereditary Breast and Ovarian Cancer Syndrome: Natural Language Processing Analysis.
Baroutsou V; Cerqueira Gonzalez Pena R; Schweighoffer R; Caiata-Zufferey M; Kim S; Hesse-Biber S; Ciorba FM; Lauer G; Katapodi M;
JMIR Form Res; 2023 Jan; 7():e38399. PubMed ID: 36656633
[TBL] [Abstract][Full Text] [Related]
20. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
